Virax Biolabs
VRAX
VRAX
2 hedge funds and large institutions have $28.6K invested in Virax Biolabs in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$24.7K |
| 2 |
2
National Bank of Canada
Montreal,
Quebec, Canada
|
$3.95K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$0 |
| 3 |
HF
3
HRT Financial
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $24.7K | 30,155 | +16,616 | +123% |
|
|
2
National Bank of Canada
Montreal,
Quebec, Canada
| $3.95K | 5,000 | +5,000 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | – | -22,425 | Closed |
|
|
TSS
4
Two Sigma Securities
New York
| – | – | -13,627 | Closed |
|
|
HF
5
HRT Financial
New York
| – | – | -13,507 | Closed |
|